Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors

Response to immunotherapy across multiple cancer types is approximately 25%, with some tumor types showing increased response rates compared to others (i.e. response rates in melanoma and non-small cell lung cancer (NSCLC) are typically 30-60%). Patients whose tumors are resistant to immunotherapy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Ivan J., Pareja, Fresia, Socci, Nicholas D., Shen, Ronglai, Doane, Ashley S., Schwartz, Jazmin, Khanin, Raya, Morris, Elizabeth A., Sutton, Elizabeth J., Blasberg, Ronald G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731115/
https://www.ncbi.nlm.nih.gov/pubmed/36505421
http://dx.doi.org/10.3389/fimmu.2022.880959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731115/
https://www.ncbi.nlm.nih.gov/pubmed/36505421
http://dx.doi.org/10.3389/fimmu.2022.880959

Ejemplares similares